MedPath

Ketorolac Tromethamine

Ketorolac Tromethamine

Approved
Approval ID

004588ba-e109-4a53-9c9d-a42dea9bb848

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 12, 2022

Manufacturers
FDA

Asclemed USA, Inc.

DUNS: 059888437

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

KETOROLAC TROMETHAMINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76420-184
Application NumberANDA074802
Product Classification
M
Marketing Category
C73584
G
Generic Name
KETOROLAC TROMETHAMINE
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateOctober 12, 2022
FDA Product Classification

INGREDIENTS (6)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 8.7 mg in 2 mL
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
KETOROLAC TROMETHAMINEActive
Quantity: 60 mg in 2 mL
Code: 4EVE5946BQ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ketorolac Tromethamine - FDA Drug Approval Details